Table 1.
Sample characteristics
| Patient (n = 164) | Spouse (n = 164) | ||
|---|---|---|---|
| Agea | 65.78 (09.93) | 61.54 (10.73) | |
| Latency since diagnosis (months)a | 05.26 (04.53) | ||
| Stage of Cancerb, c | 1 | 80 (48.8) | |
| 2 | 45 (27.4) | ||
| 3 | 17 (10.4) | ||
| 4 | 07 (04.3) | ||
| Ethnicityb | Caucasian | 142 (86.6) | 134 (81.7) |
| African American | 11 (07.6) | 09 (05.5) | |
| Hispanic | 03 (01.8) | 09 (05.5) | |
| Asian American | 05 (03.0) | 08 (04.9) | |
| Other | 03 (01.8) | 04 (02.4) | |
| Educationb | High school or less | 25 (15.2) | 42 (26.2) |
| Some college | 48 (29.3) | 55 (33.5) | |
| College graduate | 34 (20.7) | 29 (17.7) | |
| Graduate school | 57 (34.8) | 37 (22.6) | |
| Family income per yearb | Under $20,000 | 11 (06.9) | 10 (06.6) |
| $20,000–$30,000 | 15 (09.1) | 19 (11.6) | |
| $30,000–$50,000 | 37 (22.6) | 41 (25.0) | |
| $50,000–$75,000 | 46 (28.0) | 36 (22.0) | |
| Over $75,000 | 50 (30.5) | 46 (28.0) | |
| Treatment Typeb | Radical Prostatectomy | 50 (30.5) | |
| Radiation | 29 (17.7) | ||
| Orchiectomy | 4 (2.4) | ||
| Lupron/Zoladex shots | 51 (31.1) | ||
| Flutamide pills | 15 (9.1) | ||
Note.
a
M (SD).
b
n (%).
c
Stage 1: confined to prostate, Stage 2: confined to prostate, biopsy borders not clean, Stage 3: spread outside prostate, within abdomen region, Stage 4: spread beyond abdomen region